5 Jun 2020 07:00
AIM share code: SKIN
5 June 2020
Integumen PLC
("Integumen" or "Company")
Exercise of Warrants
Integumen announces that it has received notification from a warrant holder to exercise warrants over 3,333,332 shares in the share capital of Integumen ("the Warrant Shares"). The consideration for the exercise of the Warrant Shares amounts, in aggregate, to a cash value of £49,999.98.
Total voting rights
The Warrant Shares were allotted on 4 June 2020. Application has been made for the Warrant Shares to be admitted to trading on AIM ("Admission"), and Admission is expected to be on or about 10 June 2020. These shares will rank pari passu with the ordinary shares of the Company in issue.
The Company's total issued share capital, following the issue of the Warrant Shares, will be 1,078,750,235 ordinary shares. As the Company does not hold any shares in Treasury, this figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company following Admission.
Integumen plc | Gerard Brandon, CEO | +44 (0) 7340 055 648 |
|
|
|
SPARK Advisory Partners Limited (Nominated Adviser) | Neil Baldwin/Andrew Emmott | +44 (0) 113 370 8974 |
|
|
|
Turner Pope Investments (TPI) Limited (Broker) | Andy Thacker/Zoe Alexander | +44 (0) 20 3657 0050 |
|
|
|
About Integumen plc:
Integumen is a scientific research and AI-as-a-Service company focused on production and analysis of bacteria, virus and toxins utilising artificial intelligent data analytics in regulatory technology, from scientifically proving the impact of skincare product claims on skin microbiome for top 10 global cosmetic company clients to remotely detecting water contamination in real-time.